Smoking ups risk of some renal cell cancer histological subtypes

August 17, 2015
Smoking ups risk of some renal cell cancer histological subtypes

(HealthDay)—Smoking is a risk factor for clear cell and papillary renal cell carcinoma, but not for the chromophobe subtype, according to a study published in the September issue of The Journal of Urology.

Neel H. Patel, M.D., from the State University of New York in Buffalo, and colleagues examined the correlation between smoking and subtype. Data were collected from 816 patients with nonfamilial renal cell carcinoma (705) or benign pathology (111) undergoing nephrectomy.

The researchers found that 51 percent of patients reported smoking, including 21 percent active smokers and 30 percent former smokers. Compared with benign histology, active smoking was more common with clear cell or papillary cell carcinoma (23 and 26 percent, respectively, versus 14 percent; P < 0.05 each). Active smoking was less common with chromophobe renal cell carcinoma (6 percent; P < 0.05 versus clear cell or papillary). Any history was also less common with chromophobe versus clear cell or papillary histology (26 percent versus 53 percent [P = 0.003] or 58 percent [P = 0.001]). For clear cell and papillary histologies, but not chromophobe histology, independent associations with persisted after multivariable adjustment (odds ratios, 2.2 and 2.4, respectively; both P < 0.05).

"These findings underscore distinct carcinogenic mechanisms underlying the various renal cell carcinoma subtypes," the authors write.

Explore further: Smoking adversely impacts renal cell carcinoma survival

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Smoking adversely impacts renal cell carcinoma survival

February 27, 2014
(HealthDay)—For patients with clear cell renal cell carcinoma, smoking exposure adversely impacts cancer-specific survival and increases the risk of death from another cause, according to a study published in the March ...

Statins may reduce risk of progression of renal cancer

April 23, 2014
(HealthDay)—Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.

Study clarifies best treatments for uncommon kidney cancers

May 18, 2015
A head-to-head comparison of two biologic therapies used to treat a subset of patients with advanced kidney cancers provides much-needed clarity on the preferred treatment for the first line of attack.

Limited resection generally not equivalent in stage IA NSCLC

August 9, 2015
(HealthDay)—For older patients with invasive, stage IA non-small-cell lung cancer, limited resection is generally not equivalent to lobectomy, according to a study published online Aug. 3 in the Journal of Clinical Oncology.

Chemical shift MRI helps differentiate renal cell tumors more likely to metastasize

April 19, 2013
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment ...

Recommended for you

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

June 25, 2018
Survival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire study has shown.

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.